Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S1 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
  1. Home
  2. Publications
  3. Supplementary Figure S1 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

Supplementary Figure S1 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules

Authors:
  • PTPhillip Thienger
    Phillip Thienger
  • IPIrene Paassen
    Irene Paassen
  • XYXiaosai Yao
    Xiaosai Yao
  • PRPhilip D. Rubin
    Philip D. Rubin
  • MLMarika Lehner
    Marika Lehner
  • NLNicholas Lillis
    Nicholas Lillis
  • ABAndrej Benjak
    Andrej Benjak
  • SSSagar R. Shah
    Sagar R. Shah
  • ALAlden King-Yung Leung
    Alden King-Yung Leung
  • SBSimone de Brot
    Simone de Brot
  • ANAlina Naveed
    Alina Naveed
  • BDBence Daniel
    Bence Daniel

Open Access
Publisher website
Google Scholar
  • 2 April 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/0008-5472.31923203
Abstract
Drug screen with SMARCA2/4 degrader
Keywords
  • DRUG TARGETS
  • EPIGENETICS
  • HISTONE MODIFICATION
  • GENITOURINARY CANCERS
  • PROSTATE CANCER
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.